IDEAYA Biosciences (IDYA)
NASDAQ:IDYA
Holding IDYA?
Track your performance easily

IDEAYA Biosciences (IDYA) Financial Statements

469 Followers

IDEAYA Biosciences Financial Overview

IDEAYA Biosciences's market cap is currently ―. The company's EPS TTM is $-2.181; its P/E ratio is -16.40; IDEAYA Biosciences is scheduled to report earnings on November 13, 2024, and the estimated EPS forecast is $-0.65. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Jun 23Mar 23
Income Statement-
Total Revenue--$ 3.92M$ 3.54M$ 7.88M
Gross Profit--$ 3.92M$ 3.54M$ 7.88M
EBIT$ -52.77M$ -51.02M$ -41.92M$ -27.93M$ -23.64M
EBITDA$ -45.36M$ -49.94M$ -40.89M$ -29.48M$ -24.24M
Net Income Common Stockholders$ -52.77M$ -41.06M$ -33.95M$ -27.93M$ -23.64M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 701.66M$ 698.77M$ 525.11M$ 493.72M$ 339.47M
Total Assets$ 973.66M$ 961.53M$ 649.32M$ 527.56M$ 364.75M
Total Debt$ 1.87M$ 2.41M$ 2.87M$ 2.57M$ 3.03M
Net Debt$ -699.79M$ -696.37M$ -522.24M$ -491.14M$ -336.44M
Total Liabilities$ 42.01M$ 26.22M$ 28.23M$ 25.95M$ 30.94M
Stockholders Equity$ 931.67M$ 935.35M$ 621.09M$ 501.58M$ 333.81M
Cash Flow-
Free Cash Flow$ -33.85M$ -45.14M$ -24.59M$ -34.34M$ -27.89M
Operating Cash Flow$ -32.88M$ -43.81M$ -23.75M$ -33.46M$ -27.84M
Investing Cash Flow$ 68.56M$ -353.97M$ -111.94M$ -121.38M$ 23.52M
Financing Cash Flow$ 39.18M$ 349.11M$ 140.89M$ 191.06M$ 2.93M
Currency in USD

IDEAYA Biosciences Earnings and Revenue History

IDEAYA Biosciences Debt to Assets

IDEAYA Biosciences Cash Flow

IDEAYA Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis